Abstract
We evaluated the use of granulocyte CSF (G-CSF) after both allogeneic BMT (allo-BMT) and autologous BMT (ABMT) in children. After allo-BMT, G-CSF was used in 15 children who were compared with 20 historical controls. The ABMT patients were two sequential groups: the G-CSF group of 13 children and 11 historical controls. The patients were conditioned with different high-dose chemotherapy regimens with or without total body irradiation. G-CSF was administered at 5 micrograms/kg/day s.c. and was continued until an absolute neutrophil count (ANC) of 1,000 x 10(6)/l was reached. Following allo-BMT, G-CSF accelerated myeloid engraftment with a difference of 5 days at the ANC level of 500 x 10(6)/l (P<0.02) and 9 days at 1,000 x 10(6)/l (P<0.001). In the ABMT patients, G-CSF also accelerated myeloid engraftment. The difference between the G-CSF group and the control group was 6 days at ANC 200 (P<0.05), 11 days at ANC 500 (P<0.02) and 17 days at ANC 1,000 (P<0.005). In the ABMT patients, benefit by G-CSF was also observed in a smaller number of days with fever and days on antibiotics. We conclude that G-CSG significantly accelerated myeloid engraftment, after both allogeneic and autologous BMT in children, and also decreased the durat...Continue Reading
References
Oct 14, 1976·Nature·L J Guilbert, N N Iscove
Jan 1, 1992·Medical and Pediatric Oncology. Supplement·J J Nemunaitis
Feb 1, 1992·Annals of Internal Medicine·R AdvaniP L Greenberg
Jan 1, 1992·Vox Sanguinis·U M SaarinenE Juvonen
Oct 1, 1992·British Journal of Haematology·A KhwajaM J Leyland
Jan 1, 1992·Medical and Pediatric Oncology·U M SaarinenE Juvonen
Jun 15, 1992·Annals of Internal Medicine·J Noble
Dec 1, 1991·The Pediatric Infectious Disease Journal·P Riikonen
Jan 1, 1991·The American Journal of Pediatric Hematology/oncology·U M SaarinenL Hovi
Jun 20, 1991·The New England Journal of Medicine·J NemunaitisM Gold
Dec 8, 1990·Lancet·R PowlesC Tiley
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W L FurmanV M Santana
Oct 14, 1989·Lancet·W P SheridanR M Fox
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M TaylorL M Souza
May 1, 1993·The American Journal of Pediatric Hematology/oncology·J W Singer
Jan 1, 1995·Vox Sanguinis·U M SaarinenG Myllylä
Mar 1, 1994·The Pediatric Infectious Disease Journal·P RiikonenH Jalanko
Dec 1, 1993·Cancer·F R Appelbaum
Jan 1, 1993·Vox Sanguinis·U M SaarinenG Myllylä
May 1, 1993·Bone·R W NorrdinP W Gasper
Citations
Jan 28, 2005·Leukemia·M MohtyD Blaise
Jul 24, 2008·Bone Marrow Transplantation·I Badell, UNKNOWN EBMT Paediatric Working Party
Feb 14, 2002·British Journal of Haematology·Thomas Lehrnbecher, Karl Welte
Jun 1, 1997·Immunological Reviews·W J Murphy, D L Longo
Jun 19, 1997·The New England Journal of Medicine·C H PuiW E Evans
Feb 4, 2016·Pediatric Transplantation·Ciara O'RaffertyOwen P Smith
May 13, 2008·Immunobiology·Yasuhiro SuzukiSusumu Ikehara
May 9, 2006·Cancer Treatment Reviews·Brenda WittmanGary H Lyman
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick R Appelbaum
May 20, 1998·American Journal of Hematology·S H ChenH C Liu
Oct 2, 2003·Bone Marrow Transplantation·V T HoD Przepiorka
Jul 31, 2001·Bone Marrow Transplantation·C A Keever-TaylorD H Vesole
Apr 20, 2001·Paediatric Drugs·L M Wagner, W L Furman
Apr 16, 2002·Current Opinion in Hematology·John E Levine, Laurence A Boxer
May 8, 2000·Medical and Pediatric Oncology·U M Saarinen-PihkalaK Vettenranta
Jul 22, 2005·The Cochrane Database of Systematic Reviews·E C SasseS Richards
Oct 13, 2021·Pediatric Blood & Cancer·Hannah JeterEmily Waite